Immix Biopharma Inc (NASDAQ:IMMX)’s traded shares stood at 0.1 million during the last session, with the company’s beta value hitting 0.23. At the close of trading, the stock’s price was $2.55, to imply an increase of 5.81% or $0.14 in intraday trading. The IMMX share’s 52-week high remains $3.00, putting it -17.65% down since that peak but still an impressive 50.59% since price per share fell to its 52-week low of $1.26. The company has a valuation of $71.08M, with an average of 0.13 million shares in intraday trading volume over the past 10 days and average of 222.83K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Immix Biopharma Inc (IMMX), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give IMMX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
Immix Biopharma Inc (NASDAQ:IMMX) trade information
After registering a 5.81% upside in the last session, Immix Biopharma Inc (IMMX) has traded red over the past five days. The 5-day price performance for the stock is 13.84%, and 20.85% over 30 days. With these gigs, the year-to-date price performance is 20.28%. Short interest in Immix Biopharma Inc (NASDAQ:IMMX) saw shorts transact 0.25 million shares and set a 0.53 days time to cover.
The extremes give us $7 and $7 for target low and target high price respectively. As such, IMMX has been trading -174.51% off suggested target high and -174.51% from its likely low.
IMMX Dividends
Immix Biopharma Inc has its next earnings report out on 2025-May-08. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Immix Biopharma Inc (NASDAQ:IMMX)’s Major holders
Immix Biopharma Inc insiders hold 40.34% of total outstanding shares, with institutional holders owning 12.28% of the shares at 20.58% float percentage. In total, 12.28% institutions holds shares in the company, led by AIGH CAPITAL MANAGEMENT LLC. As of 2024-06-30, the company held over 1.41 million shares (or 6.0017% of shares), all amounting to roughly $2.79 million.
The next major institution holding the largest number of shares is BLEICHROEDER LP with 0.85 million shares, or about 3.6266% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $1.68 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Immix Biopharma Inc (IMMX) shares. Going by data provided on Mar 31, 2025, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 499.29 shares. This is just over 1.79% of the total shares, with a market valuation of $1.27 million. Data from the same date shows that the other fund manager holds a little less at 199.25, or 0.71% of the shares, all valued at about 0.51 million.
